JP2015110646A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015110646A5 JP2015110646A5 JP2015026203A JP2015026203A JP2015110646A5 JP 2015110646 A5 JP2015110646 A5 JP 2015110646A5 JP 2015026203 A JP2015026203 A JP 2015026203A JP 2015026203 A JP2015026203 A JP 2015026203A JP 2015110646 A5 JP2015110646 A5 JP 2015110646A5
- Authority
- JP
- Japan
- Prior art keywords
- sodium
- pharmaceutical composition
- solid pharmaceutical
- composition according
- salting
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000008194 pharmaceutical composition Substances 0.000 claims 16
- 239000007787 solid Substances 0.000 claims 16
- 230000002378 acidificating Effects 0.000 claims 9
- 239000003795 chemical substances by application Substances 0.000 claims 9
- 238000005185 salting out Methods 0.000 claims 9
- 239000000126 substance Substances 0.000 claims 9
- 150000001875 compounds Chemical class 0.000 claims 7
- 239000011780 sodium chloride Substances 0.000 claims 7
- 235000002639 sodium chloride Nutrition 0.000 claims 7
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims 6
- 150000003839 salts Chemical class 0.000 claims 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 5
- 229960002989 Glutamic Acid Drugs 0.000 claims 4
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L MgCl2 Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 claims 4
- HWPKGOGLCKPRLZ-UHFFFAOYSA-M Monosodium citrate Chemical compound [Na+].OC(=O)CC(O)(C([O-])=O)CC(O)=O HWPKGOGLCKPRLZ-UHFFFAOYSA-M 0.000 claims 4
- GEHJYWRUCIMESM-UHFFFAOYSA-L Sodium sulfite Chemical compound [Na+].[Na+].[O-]S([O-])=O GEHJYWRUCIMESM-UHFFFAOYSA-L 0.000 claims 4
- 125000005843 halogen group Chemical group 0.000 claims 4
- 239000002524 monosodium citrate Substances 0.000 claims 4
- 235000018342 monosodium citrate Nutrition 0.000 claims 4
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 claims 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims 4
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims 3
- 229960003707 glutamic acid hydrochloride Drugs 0.000 claims 3
- VZCYOOQTPOCHFL-OWOJBTEDSA-N (E)-but-2-enedioate;hydron Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 claims 2
- KRKNYBCHXYNGOX-UHFFFAOYSA-K 2qpq Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 claims 2
- WNLRTRBMVRJNCN-UHFFFAOYSA-N Adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 claims 2
- 229940049906 Glutamate Drugs 0.000 claims 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N HCl Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M NaHCO3 Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 claims 2
- 125000000217 alkyl group Chemical group 0.000 claims 2
- 125000003277 amino group Chemical group 0.000 claims 2
- 125000004432 carbon atoms Chemical group C* 0.000 claims 2
- 125000004435 hydrogen atoms Chemical group [H]* 0.000 claims 2
- 229910001629 magnesium chloride Inorganic materials 0.000 claims 2
- 235000011147 magnesium chloride Nutrition 0.000 claims 2
- PMZURENOXWZQFD-UHFFFAOYSA-L na2so4 Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 claims 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims 2
- 239000001103 potassium chloride Substances 0.000 claims 2
- 235000011164 potassium chloride Nutrition 0.000 claims 2
- DWAQJAXMDSEUJJ-UHFFFAOYSA-M sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 claims 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L sodium carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims 2
- 229940079827 sodium hydrogen sulfite Drugs 0.000 claims 2
- 235000010267 sodium hydrogen sulphite Nutrition 0.000 claims 2
- 235000011121 sodium hydroxide Nutrition 0.000 claims 2
- 229910052938 sodium sulfate Inorganic materials 0.000 claims 2
- 235000011152 sodium sulphate Nutrition 0.000 claims 2
- 235000010265 sodium sulphite Nutrition 0.000 claims 2
- RPAJSBKBKSSMLJ-DFWYDOINSA-N (2S)-2-aminopentanedioic acid;hydrochloride Chemical compound Cl.OC(=O)[C@@H](N)CCC(O)=O RPAJSBKBKSSMLJ-DFWYDOINSA-N 0.000 claims 1
- XJKJWTWGDGIQRH-BFIDDRIFSA-N Alginic acid Chemical compound O1[C@@H](C(O)=O)[C@@H](OC)[C@H](O)[C@H](O)[C@@H]1O[C@@H]1[C@@H](C(O)=O)O[C@@H](C)[C@@H](O)[C@H]1O XJKJWTWGDGIQRH-BFIDDRIFSA-N 0.000 claims 1
- PRKQVKDSMLBJBJ-UHFFFAOYSA-N Ammonium carbonate Chemical compound N.N.OC(O)=O PRKQVKDSMLBJBJ-UHFFFAOYSA-N 0.000 claims 1
- 229960005261 Aspartic Acid Drugs 0.000 claims 1
- VSGNNIFQASZAOI-UHFFFAOYSA-L Calcium acetate Chemical compound [Ca+2].CC([O-])=O.CC([O-])=O VSGNNIFQASZAOI-UHFFFAOYSA-L 0.000 claims 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate dianion Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 claims 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L Dipotassium phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 claims 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 claims 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N Malic acid Chemical compound OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 claims 1
- FEWJPZIEWOKRBE-XIXRPRMCSA-N Mesotartaric acid Chemical compound OC(=O)[C@@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-XIXRPRMCSA-N 0.000 claims 1
- 229940117841 Methacrylic Acid Copolymer Drugs 0.000 claims 1
- GNSKLFRGEWLPPA-UHFFFAOYSA-M Monopotassium phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 claims 1
- TYJJADVDDVDEDZ-UHFFFAOYSA-M Potassium bicarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 claims 1
- 229960004249 Sodium Acetate Drugs 0.000 claims 1
- 229940073490 Sodium Glutamate Drugs 0.000 claims 1
- AQMNWCRSESPIJM-UHFFFAOYSA-M Sodium metaphosphate Chemical compound [Na+].[O-]P(=O)=O AQMNWCRSESPIJM-UHFFFAOYSA-M 0.000 claims 1
- FWYVLGJBTZNHEM-UHFFFAOYSA-H Sodiumpolyphosphate Chemical compound [Na+].[O-]P(=O)=O.[O-]P(=O)=O.[O-]P(=O)=O.[O-]P(=O)=O.[O-]P(=O)=O.[O-]P(=O)=O FWYVLGJBTZNHEM-UHFFFAOYSA-H 0.000 claims 1
- 229960005137 Succinic Acid Drugs 0.000 claims 1
- FQENQNTWSFEDLI-UHFFFAOYSA-J Tetrasodium pyrophosphate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]P([O-])(=O)OP([O-])([O-])=O FQENQNTWSFEDLI-UHFFFAOYSA-J 0.000 claims 1
- HRXKRNGNAMMEHJ-UHFFFAOYSA-K Trisodium citrate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 claims 1
- RFRIWRLHYDZFRS-UHFFFAOYSA-N [Na].[Na].[Na].P(O)(O)(O)=O Chemical compound [Na].[Na].[Na].P(O)(O)(O)=O RFRIWRLHYDZFRS-UHFFFAOYSA-N 0.000 claims 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K [O-]P([O-])([O-])=O Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 claims 1
- 150000001242 acetic acid derivatives Chemical class 0.000 claims 1
- 239000001361 adipic acid Substances 0.000 claims 1
- 235000011037 adipic acid Nutrition 0.000 claims 1
- 229960000250 adipic acid Drugs 0.000 claims 1
- 239000000783 alginic acid Substances 0.000 claims 1
- 235000010443 alginic acid Nutrition 0.000 claims 1
- 229960001126 alginic acid Drugs 0.000 claims 1
- 229920000615 alginic acid Polymers 0.000 claims 1
- 239000001099 ammonium carbonate Substances 0.000 claims 1
- 235000012501 ammonium carbonate Nutrition 0.000 claims 1
- 235000003704 aspartic acid Nutrition 0.000 claims 1
- 125000004429 atoms Chemical group 0.000 claims 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L cacl2 Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 claims 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims 1
- 239000011575 calcium Substances 0.000 claims 1
- 229910052791 calcium Inorganic materials 0.000 claims 1
- 239000001639 calcium acetate Substances 0.000 claims 1
- 235000011092 calcium acetate Nutrition 0.000 claims 1
- 229960005147 calcium acetate Drugs 0.000 claims 1
- 239000001110 calcium chloride Substances 0.000 claims 1
- 229910001628 calcium chloride Inorganic materials 0.000 claims 1
- 235000011148 calcium chloride Nutrition 0.000 claims 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 claims 1
- 229960004106 citric acid Drugs 0.000 claims 1
- 235000015165 citric acid Nutrition 0.000 claims 1
- 150000001860 citric acid derivatives Chemical class 0.000 claims 1
- 125000004093 cyano group Chemical group *C#N 0.000 claims 1
- 235000019797 dipotassium phosphate Nutrition 0.000 claims 1
- 229910000396 dipotassium phosphate Inorganic materials 0.000 claims 1
- ZDQYSKICYIVCPN-UHFFFAOYSA-L disodium butanedioate Chemical compound [Na+].[Na+].[O-]C(=O)CCC([O-])=O ZDQYSKICYIVCPN-UHFFFAOYSA-L 0.000 claims 1
- 239000002526 disodium citrate Substances 0.000 claims 1
- 235000019262 disodium citrate Nutrition 0.000 claims 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 claims 1
- CEYULKASIQJZGP-UHFFFAOYSA-L disodium;2-(carboxymethyl)-2-hydroxybutanedioate Chemical compound [Na+].[Na+].[O-]C(=O)CC(O)(C(=O)O)CC([O-])=O CEYULKASIQJZGP-UHFFFAOYSA-L 0.000 claims 1
- 238000007908 dry granulation Methods 0.000 claims 1
- 229910052731 fluorine Inorganic materials 0.000 claims 1
- 125000001153 fluoro group Chemical group F* 0.000 claims 1
- 239000001530 fumaric acid Substances 0.000 claims 1
- 239000004220 glutamic acid Substances 0.000 claims 1
- 235000013922 glutamic acid Nutrition 0.000 claims 1
- 150000002306 glutamic acid derivatives Chemical class 0.000 claims 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 1
- 229910052739 hydrogen Inorganic materials 0.000 claims 1
- 239000001257 hydrogen Substances 0.000 claims 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 1
- 239000001630 malic acid Substances 0.000 claims 1
- 235000011090 malic acid Nutrition 0.000 claims 1
- 229940099690 malic acid Drugs 0.000 claims 1
- 229920003145 methacrylic acid copolymer Polymers 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 claims 1
- 235000019796 monopotassium phosphate Nutrition 0.000 claims 1
- LPUQAYUQRXPFSQ-UHFFFAOYSA-M monosodium glutamate Chemical compound [Na+].[O-]C(=O)C(N)CCC(O)=O LPUQAYUQRXPFSQ-UHFFFAOYSA-M 0.000 claims 1
- 235000013923 monosodium glutamate Nutrition 0.000 claims 1
- 235000019799 monosodium phosphate Nutrition 0.000 claims 1
- 229910000403 monosodium phosphate Inorganic materials 0.000 claims 1
- 239000010452 phosphate Substances 0.000 claims 1
- 239000011736 potassium bicarbonate Substances 0.000 claims 1
- 229910000028 potassium bicarbonate Inorganic materials 0.000 claims 1
- 235000015497 potassium bicarbonate Nutrition 0.000 claims 1
- 239000001184 potassium carbonate Substances 0.000 claims 1
- 229910000027 potassium carbonate Inorganic materials 0.000 claims 1
- 235000015320 potassium carbonate Nutrition 0.000 claims 1
- 229940086066 potassium hydrogencarbonate Drugs 0.000 claims 1
- LWIHDJKSTIGBAC-UHFFFAOYSA-K potassium phosphate Substances [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 claims 1
- VMHLLURERBWHNL-UHFFFAOYSA-M sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 claims 1
- 239000001632 sodium acetate Substances 0.000 claims 1
- 235000017281 sodium acetate Nutrition 0.000 claims 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 claims 1
- 235000017557 sodium bicarbonate Nutrition 0.000 claims 1
- 239000001187 sodium carbonate Substances 0.000 claims 1
- 229910000029 sodium carbonate Inorganic materials 0.000 claims 1
- 235000017550 sodium carbonate Nutrition 0.000 claims 1
- 239000001509 sodium citrate Substances 0.000 claims 1
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 claims 1
- 235000019983 sodium metaphosphate Nutrition 0.000 claims 1
- 235000019830 sodium polyphosphate Nutrition 0.000 claims 1
- 229940048086 sodium pyrophosphate Drugs 0.000 claims 1
- 229940086735 succinate Drugs 0.000 claims 1
- 150000003890 succinate salts Chemical class 0.000 claims 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 claims 1
- 239000001384 succinic acid Substances 0.000 claims 1
- 235000011044 succinic acid Nutrition 0.000 claims 1
- 239000011975 tartaric acid Substances 0.000 claims 1
- 235000002906 tartaric acid Nutrition 0.000 claims 1
- 229960001367 tartaric acid Drugs 0.000 claims 1
- 235000019818 tetrasodium diphosphate Nutrition 0.000 claims 1
- 239000001577 tetrasodium phosphonato phosphate Substances 0.000 claims 1
- 239000011778 trisodium citrate Substances 0.000 claims 1
- 235000019263 trisodium citrate Nutrition 0.000 claims 1
Claims (15)
- 一般式(1):
(式中、R1はハロゲン原子、アミノ基またはシアノ基で1または2以上置換されていてもよい炭素数1から3のアルキル基を示し、R2は炭素数1から3のアルキル基、水素原子、ハロゲン原子、水酸基またはアミノ基を示し、R3は水素原子またはハロゲン原子を示し、R4は水素原子またはフッ素原子を示し、Xはハロゲン原子を示す)で表される化合物またはその塩、並びに無機塩、クエン酸塩、コハク酸塩、酢酸塩、及びグルタミン酸塩からなる群から選択される1種または2種以上の塩析剤を含有する固形医薬組成物。 - pHが3.5以下である酸性物質をさらに含有する、請求項1に記載の固形医薬組成物。
- 前記酸性物質の20℃における水への溶解度が10%未満である、請求項2に記載の固形医薬組成物。
- 前記20℃における水への溶解度が10%未満の酸性物質として、アルギン酸、グルタミン酸、アスパラギン酸、アジピン酸、コハク酸、メタクリル酸コポリマーL及びフマル酸からなる群より選ばれる1種または2種以上の化合物を含有する請求項3に記載の固形医薬組成物。
- 前記酸性物質の20℃における水への溶解度が10%以上である、請求項2に記載の固形医薬組成物。
- 前記20℃における水への溶解度が10%以上の酸性物質として、グルタミン酸塩酸塩、酒石酸、クエン酸及びリンゴ酸からなる群より選ばれる1種または2種以上の化合物を含有する請求項5に記載の固形医薬組成物。
- 前記20℃における水への溶解度が10%以上の酸性物質が、前記塩析剤とは異なる化合物であり、当該酸性物質の割合が、前記一般式(1)で表される化合物またはその塩1質量部に対して、0.001質量部以上0.05質量部以下である、請求項5または請求項6に記載の固形医薬組成物。
- 前記塩析剤として、クエン酸塩、コハク酸塩、酢酸塩、リン酸塩、炭酸塩、硫酸ナトリウム、亜硫酸ナトリウム、亜硫酸水素ナトリウム、塩化カルシウム、塩化ナトリウム、塩化カリウム、塩化マグネシウム、水酸化ナトリウム、及びグルタミン酸塩からなる群から選択される1種または2種以上の化合物を含有する請求項1乃至7のいずれか1項に記載の固形医薬組成物。
- 前記塩析剤として、クエン酸二水素ナトリウム、クエン酸二ナトリウム、クエン酸ナトリウム、コハク酸二ナトリウム、酢酸カルシウム、酢酸ナトリウム、リン酸二水素ナトリウム、リン酸水素二ナトリウム、メタリン酸ナトリウム、リン酸三ナトリウム、リン酸二水素カリウム、リン酸二カリウム、ポリリン酸ナトリウム、ピロリン酸ナトリウム、炭酸ナトリウム、炭酸水素ナトリウム、炭酸カリウム、炭酸水素カリウム、炭酸アンモニウム、硫酸ナトリウム、亜硫酸ナトリウム、亜硫酸水素ナトリウム、塩化カルシウム、塩化ナトリウム、塩化カリウム、塩化マグネシウム、水酸化ナトリウム、L−グルタミン酸塩酸塩、及びグルタミン酸ナトリウムからなる群から選択される1種または2種以上の化合物を含有する請求項1乃至7のいずれか1項に記載の固形医薬組成物。
- 前記塩析剤として、クエン酸塩を含有する請求項1乃至7のいずれか1項に記載の固形医薬組成物。
- 前記塩析剤として、クエン酸二水素ナトリウムを含有する請求項1乃至7のいずれか1項に記載の固形医薬組成物。
- 前記塩析剤としてクエン酸二水素ナトリウムを、前記酸性物質としてグルタミン酸塩酸塩を含有し、グルタミン酸塩酸塩の割合が、クエン酸二水素ナトリウム1質量部に対し0.02質量部以上0.20質量部以下である請求項2または請求項5乃至7のうちいずれか1つに記載の固形医薬組成物。
- 前記塩析剤且つ前記酸性物質である化合物として、グルタミン酸塩酸塩を含有する請求項2に記載の固形医薬組成物。
- 前記一般式(1)で表される化合物またはその塩、及び前記塩析剤を混合し、得られた混合物を乾式造粒法により造粒することを含む方法により得られる請求項1乃至13のうちいずれか1つに記載の固形医薬組成物。
- 前記一般式(1)で表される化合物の塩として、塩酸塩を含有する請求項1乃至14のいずれか1項に記載の固形医薬組成物。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2015026203A JP6397778B2 (ja) | 2013-04-25 | 2015-02-13 | 固形医薬組成物 |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2013092169 | 2013-04-25 | ||
JP2013092169 | 2013-04-25 | ||
JP2015026203A JP6397778B2 (ja) | 2013-04-25 | 2015-02-13 | 固形医薬組成物 |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2014541239A Division JP5700740B1 (ja) | 2013-04-25 | 2014-04-24 | 固形医薬組成物 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2018164140A Division JP6689333B2 (ja) | 2013-04-25 | 2018-09-03 | 固形医薬組成物 |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2015110646A JP2015110646A (ja) | 2015-06-18 |
JP2015110646A5 true JP2015110646A5 (ja) | 2017-06-15 |
JP6397778B2 JP6397778B2 (ja) | 2018-09-26 |
Family
ID=51791435
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2014541239A Active JP5700740B1 (ja) | 2013-04-25 | 2014-04-24 | 固形医薬組成物 |
JP2015026203A Active JP6397778B2 (ja) | 2013-04-25 | 2015-02-13 | 固形医薬組成物 |
JP2018164140A Active JP6689333B2 (ja) | 2013-04-25 | 2018-09-03 | 固形医薬組成物 |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2014541239A Active JP5700740B1 (ja) | 2013-04-25 | 2014-04-24 | 固形医薬組成物 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2018164140A Active JP6689333B2 (ja) | 2013-04-25 | 2018-09-03 | 固形医薬組成物 |
Country Status (6)
Country | Link |
---|---|
US (1) | US9687453B2 (ja) |
EP (1) | EP2990039A4 (ja) |
JP (3) | JP5700740B1 (ja) |
CN (1) | CN105338981B (ja) |
CA (1) | CA2910121A1 (ja) |
WO (1) | WO2014174847A1 (ja) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105338982B (zh) * | 2013-04-25 | 2017-10-10 | 杏林制药株式会社 | 固体药用组合物 |
EP3210607A4 (en) * | 2014-10-23 | 2018-06-06 | Kyorin Pharmaceutical Co., Ltd. | Solid pharmaceutical composition |
EP3305294A4 (en) * | 2015-06-02 | 2019-02-20 | Kyorin Pharmaceutical Co., Ltd. | AQUEOUS MEDICINE |
WO2016195020A1 (ja) * | 2015-06-02 | 2016-12-08 | 杏林製薬株式会社 | 水性液剤 |
CA2988092A1 (en) * | 2015-06-02 | 2016-12-08 | Kyorin Pharmaceutical Co., Ltd. | Aqueous liquid formulation |
JP6031216B1 (ja) * | 2015-06-02 | 2016-11-24 | 杏林製薬株式会社 | 水性液剤 |
JP6031217B1 (ja) * | 2015-06-02 | 2016-11-24 | 杏林製薬株式会社 | 水性液剤 |
CN110662534A (zh) * | 2017-05-31 | 2020-01-07 | 勃林格殷格翰国际有限公司 | 包含(e)-4-(2-(氨基甲基)-3-氟烯丙基氧基)-n-叔丁基苯甲酰胺的药物组合物和药物剂型,其制备方法、治疗方法及用途 |
SG11202001436YA (en) * | 2017-08-18 | 2020-03-30 | Abbvie Inc | Pharmaceutical formulations for treating endometriosis, uterine fibroids, polycystic ovary syndrome or adenomyosis |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8524001D0 (en) | 1985-09-30 | 1985-11-06 | Glaxo Group Ltd | Pharmaceutical composition |
EP1066040B1 (en) | 1998-03-03 | 2003-02-19 | Daewoong Pharmaceutical Co., Ltd. | Pharmaceutical composition containing cefuroxime axetil stable for moisture absorption |
AT413647B (de) | 1998-11-26 | 2006-04-15 | Sandoz Ag | Verwendung eines copolymerisats aus 1-vinyl-2-pyrrolidon und vinylacetat zur herstellung von cefuroximaxetil-hältigen tabletten |
DE10048510A1 (de) | 2000-09-29 | 2002-05-16 | Fresenius Kabi De Gmbh | Lagerstabile Infusionslösung des Ciprofloxacins mit verringertem Säuregehalt |
BR0207640A (pt) * | 2001-02-27 | 2004-07-27 | Ranbaxy Lab Ltd | Composição farmacêutica oral de cefpodoxima proxetil |
EP1459739B1 (en) | 2003-03-19 | 2008-01-02 | The Jordanian Pharmaceutical Manufacturing Co. Ltd. | Non-hygroscopic pharmaceutical compositions containing non-hydrated quinoline carboxylic acids |
AU2004272414B2 (en) * | 2003-09-10 | 2009-05-28 | Kyorin Pharmaceutical Co., Ltd. | 7-(4-substituted 3- cyclopropylaminomethyl-1- pyrrolidinyl) quinolonecarboxylic acid derivative |
EP1764102A4 (en) | 2004-07-02 | 2010-08-25 | Daiichi Seiyaku Co | MEDICINAL COMPOSITION CONTAINING QUINOLONE |
JP4834553B2 (ja) | 2004-09-17 | 2011-12-14 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | 医薬組成物 |
US20080031942A1 (en) | 2004-12-03 | 2008-02-07 | Takeda Pharmaceutical Company Limited | Solid Preparation |
JP2006298811A (ja) | 2005-04-20 | 2006-11-02 | Taiyo Yakuhin Kogyo Kk | ゲル化抑制製剤の設計 |
SA112330992B1 (ar) * | 2011-11-10 | 2015-09-13 | كيورين فارماسوتيكال كو.، ليمتد | صورة متبلرة من 7-{(s4، s3)-3-[(سيكلو بروبيل أمينو) ميثيل]-4-فلورو بيروليدين-1-يل}-6-فلورو-1-(2-فلورو إيثيل)- 8-ميثوكسي-4-أوكسو-1، 4-داي هيدرو كينولين-3- حمض كربوكسيلي |
JP6062422B2 (ja) * | 2012-03-29 | 2017-01-18 | 杏林製薬株式会社 | カプセル製剤 |
JP6050322B2 (ja) * | 2012-03-29 | 2016-12-21 | 杏林製薬株式会社 | カプセル製剤 |
CN105338982B (zh) * | 2013-04-25 | 2017-10-10 | 杏林制药株式会社 | 固体药用组合物 |
-
2014
- 2014-04-24 CA CA2910121A patent/CA2910121A1/en not_active Abandoned
- 2014-04-24 US US14/786,412 patent/US9687453B2/en active Active
- 2014-04-24 JP JP2014541239A patent/JP5700740B1/ja active Active
- 2014-04-24 WO PCT/JP2014/002309 patent/WO2014174847A1/ja active Application Filing
- 2014-04-24 CN CN201480036230.1A patent/CN105338981B/zh active Active
- 2014-04-24 EP EP14789034.7A patent/EP2990039A4/en not_active Withdrawn
-
2015
- 2015-02-13 JP JP2015026203A patent/JP6397778B2/ja active Active
-
2018
- 2018-09-03 JP JP2018164140A patent/JP6689333B2/ja active Active
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2015110646A5 (ja) | ||
JP2015078201A5 (ja) | ||
MY201524A (en) | Novel compounds as autotaxin inhibitors and pharmaceutical compositions comprising the same | |
GEP20207105B (en) | 1,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives and 1,1,1-trifluoro-4-hydroxybutan-2yl carbamate derivatives as magl inhibitors | |
CN104071906B (zh) | 高效复合阻垢缓蚀剂 | |
MX2018009944A (es) | Procedimiento para la preparacion del acido 4-fenil-5-alcoxicarbon il-2-tiazol-2-il-1,4-dihidropirimidin-6-il-[metil]3-oxo-5,6,8,8a- tetrahidro-1h-imidazo[1,5a]pirazin-2-il-carboxilico. | |
JP2013523802A5 (ja) | ||
MX2021004015A (es) | Compuestos de aminoacidos y metodos de uso. | |
JP2017222882A5 (ja) | ||
HRP20120416T1 (hr) | Postupci pripreme i uporabe smjesa kelata feri pirofosfat citrata | |
JP2018021007A5 (ja) | ||
PH12017502009A1 (en) | Novel sulfonimidoylpurinone compounds and derivatives for the treatment and prophylaxis of virus infection | |
MX2021006951A (es) | Formas cristalinas y formas de sal de un inhibidor de cinasa. | |
MX2018006390A (es) | Composiciones y metodos para tratar accidente cerebrovascular isquemico. | |
CN106521507A (zh) | 铝合金化学抛光添加剂 | |
NZ738836A (en) | Solid forms of (z)-4-(5-((3-benzyl-4-oxo-2-thioxothiazolidin-5-ylidene)methyl)furan-2-yl)benzoic acid | |
JP2018511644A5 (ja) | ||
MA39715A (fr) | Formes polymorphes de l'acide 4,5-dihydro-1h-pyrrolo[2,3-f]quinoline-2,7,9-tricarboxylique et de son sel de disodium, procédé de préparation desdites formes polymorphes et leur utilisation | |
MX2020005335A (es) | Fertilizantes novedosos fosfaticos basados en sakes de alcanolamina de acido fosforico. | |
MX2022000762A (es) | Formulaciones orales de edaravone y metodo de fabricacion de las mismas. | |
RS54021B1 (en) | STABLE S-ADENOSYLMETHIONINE SALTS AND PROCEDURE FOR THEIR PRODUCTION | |
JP2021504302A5 (ja) | ||
SA516370648B1 (ar) | تركيبات سماد حمضية تحتوي على معقد معدن من حمض جلوتاميك، حمض n، n- داي أسيتيك أو حمض إيمينو داي سكسينيك | |
CR20210394A (es) | Formas de sal y cristalinas de un compuesto orgánico y composiciones farmacéuticas del mismo | |
JP2014137599A5 (ja) |